Works matching Tyrosine kinase inhibitors (cancer treatment)

Results: 369
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study.

    Published in:
    2020
    By:
    • Minari, Roberta;
    • Mazzaschi, Giulia;
    • Bordi, Paola;
    • Gnetti, Letizia;
    • Alberti, Giorgia;
    • Altimari, Annalisa;
    • Gruppioni, Elisa;
    • Sperandi, Francesca;
    • Parisi, Claudia;
    • Guaitoli, Giorgia;
    • Bettelli, Stefania;
    • Longo, Lucia;
    • Bertolini, Federica;
    • Pagano, Maria;
    • Bonelli, Candida;
    • Tagliavini, Elena;
    • Nicoli, Davide;
    • Ubiali, Alessandro;
    • Zangrandi, Adriano;
    • Trubini, Serena
    Publication type:
    journal article
    10
    11
    12
    13
    14
    15
    16
    17

    Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.

    Published in:
    Journal of Neurosurgery, 2022, v. 137, n. 2, p. 563, doi. 10.3171/2021.9.JNS211373
    By:
    • Guan-Ying Chiou;
    • Chi-Lu Chiang;
    • Huai-Che Yang;
    • Chia-I Shen;
    • Hsiu-Mei Wu;
    • Yu-Wei Chen;
    • Ching-Jen Chen;
    • Yung-Hung Luo;
    • Yong-Sin Hu;
    • Chung-Jung Lin;
    • Wen-Yuh Chung;
    • Cheng-Ying Shiau;
    • Wan-Yuo Guo;
    • Hung-Chi Pan, David;
    • Cheng-Chia Lee
    Publication type:
    Article
    18

    Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2018, v. 142, n. 3, p. 321, doi. 10.5858/arpa.2017-0388-CP
    By:
    • Lindeman, Neal I.;
    • Cagle, Philip T.;
    • Aisner, Dara L.;
    • Arcila, Maria E.;
    • Beasley, Mary Beth;
    • Bernicker, Eric H.;
    • Colasacco, Carol;
    • Dacic, Sanja;
    • Hirsch, Fred R.;
    • Kerr, Keith;
    • Kwiatkowski, David J.;
    • Ladanyi, Marc;
    • Nowak, Jan A.;
    • Sholl, Lynette;
    • Temple-Smolkin, Robyn;
    • Solomon, Benjamin;
    • Souter, Lesley H.;
    • Thunnissen, Erik;
    • Ming S. Tsao;
    • Ventura, Christina B.
    Publication type:
    Article
    19
    20

    Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens

    Published in:
    Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 531, doi. 10.1007/s40801-023-00383-1
    By:
    • Marrett, Elizabeth;
    • Kwong, Winghan Jacqueline;
    • Xie, Jipan;
    • Manceur, Ameur M.;
    • Sendhil, Selvam R.;
    • Wu, Eric;
    • Ionescu-Ittu, Raluca;
    • Subramanian, Janakiraman
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study.

    Published in:
    Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1623, doi. 10.1177/1078155220963535
    By:
    • Benekli, Mustafa;
    • Gumus, Mahmut;
    • Ozkan, Metin;
    • Dane, Faysal;
    • Elkiran, Emin T.;
    • Cicin, Irfan;
    • Sevinc, Alper;
    • Aliustaoglu, Mehmet;
    • Isikdogan, Abdurrahman;
    • Meydan, Nezih;
    • Oksuzoglu, Berna;
    • Ozyilkan, Ozgur;
    • Artac, Mehmet;
    • Ozdemir, Feyyaz;
    • Kilickap, Sadettin
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Mass Spectrometry to Classify Non-Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicohort Cross-Institutional Study.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 11, p. 838, doi. 10.1093/jnci/djk195
    By:
    • Taguchi, Fumiko;
    • Solomon, Benjamin;
    • Gregorc, Vanesa;
    • Roder, Heinrich;
    • Gray, Robert;
    • Kasahara, Kazuo;
    • Nishio, Makoto;
    • Brahmer, Julie;
    • Spreafico, Anna;
    • Ludovini, Vienna;
    • Massion, Pierre P.;
    • Dziadziuszko, Rafal;
    • Schiller, Joan;
    • Grigorieva, Julia;
    • Tsypin, Maxim;
    • Hunsucker, Stephen W.;
    • Caprioli, Richard;
    • Duncan, Mark W.;
    • Hirsch, Fred R.;
    • Bunn Jr, Paul A.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50